The prognostic value of RDW, NLR and PLR in sequential radio-chemotherapy for advanced lung cancer

Iwona Jabłońska, Marcin Miszczyk, Marcin Goławski, Iwona Dębosz-Suwińska, Rafał Suwiński

Vol 72, No 3 (2022)

Research paper (original)

The role of genetic counselling in oncology

Agnieszka Stembalska, Karolina Pesz

Vol 72, No 3 (2022)

Other materials agreed with the Editors

Assessment of the effectiveness of clinical PSA concentration measurements in early prostate cancer detection

Tomasz Tatara, Wojciech Miazga, Jakub Świtalski, Katarzyna Wnuk, Magdalena Jabłońska, Adrian Matera, Dagmara Karauda, Agnieszka Zagrobelna, Sylwia Jopek

Vol 72, No 3 (2022)

Review paper

Epithelioid sarcoma

Anna M. Czarnecka

Vol 73, No 3 (2023)

Review paper

Immunological aspects of heat shock protein functions and their significance in the development of cancer vaccines

Iryna Boliukh, Agnieszka Rombel-Bryzek, Barbara Radecka

Vol 72, No 3 (2022)

Review paper

Sexual Health in breast cancer patients in Poland

Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk

Vol 72, No 2 (2022)

Research paper (original)

Polish consensus on gastric cancer diagnosis and treatment – update 2022

Piotr Richter, Grzegorz Wallner, Wojciech Zegarski, Marek Sierżęga, Piotr Kołodziejczyk, Anna Nasierowska-Guttmejer, Wojciech Kielan, Dawid Murawa, Lucjan Wyrwicz, Kamil Konopka, Radosław Pach, Rafał Stec, Michał Kukla, Tomasz Skoczylas, Antoni Szczepanik, Polish Gastric Cancer Research Group

Vol 72, No 5 (2022)

Guidelines / Expert consensus

Dose estimation in patients treated with radiotherapy for SARS-COVID disease based on EPID measurement

Krzysztof Ślosarek, Tomasz Rutkowski, Adam Gądek, Łukasz Sroka, Łukasz Dolla, Roman Rutkowski, Jerzy Jaroszkiewicz

Vol 72, No 2 (2022)

Research paper (original)

The dose no longer plays a paramount role in radiotherapy (oncology), but time apparently does

Bogusław Maciejewski, Krzysztof Składowski

Vol 72, No 2 (2022)

Review paper

Complementary and alternative therapies in oncology

Joanna Kufel-Grabowska, Mikołaj Bartoszkiewicz

Vol 72, No 2 (2022)

Invited editorial

Peritoneal recurrence of RCC and gastric cancer treated with cytoreductive surgery and HIPEC

Tomasz Jastrzębski, Marian Brodecki, Michał Spychalski, Tomasz Sylwestrzak, Adam Dziki

Vol 72, No 3 (2022)

Pictures in Oncology

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski, Dominik Dziurda, Mariusz Bidziński, Barbara Bobek-Bilewicz, Marek Dedecjus, Iwona Hus, Beata Jagielska, Jacek Jassem, Andrzej Kawecki, Dariusz Kowalski, Magdalena Krasztel, Maciej Krzakowski, Tomasz Kubiatowski, Piotr Potemski, Radosław Mądry, Piotr Rutkowski, Anna Rychert, Janusz Ryś, Krzysztof Składowski, Rafał Tarnawski, Hanna Tchórzewska-Korba, Andrzej Tysarowski, Piotr J. Wysocki, Roman Topór-Mądry

Vol 72, No 1 (2022)

Guidelines / Expert consensus

Methotrexate-associated oral mucositis in children with acute lymphoblastic leukemia

Ewa Pustelnik, Katarzyna Pikora, Katarzyna Pawelec

Vol 73, No 5 (2023)

Review paper

Implementation of a population-based breast cancer prevention program in Poland before, during and after the COVID-19 pandemic. Poland in comparison with other countries

Mariola W. Borowska, Urszula Religioni, Anna Augustynowicz

Vol 73, No 3 (2023)

Research paper (original)

The importance of selected biomarkers in the clinical practice of breast cancer patients

Agata Makówka, Beata Kotowicz

Vol 73, No 5 (2023)

Review paper